BOULDING MARK ELLIOTT (Exec. VP and CLO) sold 2.6% of their position (2.81K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $203.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/19/2026ACC: 0001578852-26-000016
Officer· Exec. VP and CLO
Since Jan 2019
-2.81K
Net shares
Net seller
$203.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
2.81K acquired · 5.62K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+2.81K
Price / share
$25.69
Trade value
$72.24K
% of position
2.7%
5/15/2026
105.21K→108.02K
Common Stock
Direct
Shares
−2.36K
Price / share
$72.08
Trade value
$169.82K
% of position
2.2%
5/15/2026
108.02K→105.67K
Common Stock
Direct
Shares
−456.00
Price / share
$72.67
Trade value
$33.14K
% of position
0.4%
5/15/2026
105.67K→105.21K
Total
Net shares
+0.00
Net value
-$130.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | M · Option Exercise | +2.81K | $25.69 | $72.24K | 2.7% | 105.21K | 108.02K |
| Common Stock Direct | 5/15/2026 | S · Sale | −2.36K | $72.08 | $169.82K | 2.2% | 108.02K | 105.67K |
| Common Stock Direct | 5/15/2026 | S · Sale | −456.00 | $72.67 | $33.14K | 0.4% | 105.67K | 105.21K |
| Total | +0.00 | -$130.72K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
2.81K shares
Shares
−2.81K
Strike price
25.69
Held after
19.69K
Exercisable
—
5/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock2.81K shares | 5/15/2026 | M · Option Exercise | −2.81K | 25.69 | — | 19.69K |